|
NEWS & ANNOUNCEMENTS |
|
|
| |
|
|
| |
|
|
| |
NeuroVigil wishes Prof. Stephen Hawking a Very Happy Birthday
The Telegraph, 21 Jan 2012
"Despite his health — and the fact that he has done more than enough to be considered for a Nobel Prize — Hawking is still pushing on with his research. His most recent major paper, written with Thomas Hertog in Paris and Jim Hartle in California, came up with a deeper understanding of cosmic inflation, the astonishing growth spurt of the early universe."
|
|
|
| |
Caltech Biotech Club — Dr. Philip Low, NeuroVigil Founder, Chairman & CEO
Caltech, 8 Dec 2011
"From the Salk Institute to NeuroVigil: Building iBrain and the World's
First Computational Neurodiagnostics Company from Scratch"
Dr. Philip Low will provide an overview of NeuroVigil's activities in computational
neuroscience, wireless, hardware and neural engineering, and will cover
NeuroVigil's diverse projects on CNS neuropathologies from Pharma clinical trials
to the company's new partnership with Professor Stephen Hawking. Dr. Low will
also discuss how he was able to bootstrap the company to revenue, without
institutional support to secure one of the highest seed valuations in startup history.
|
|
|
| |
|
|
| |
Dr. Philip Low Wins Inaugural Jacobs-Rady Pioneer Award
NeuroVigil, 6 Jun 2011
On the occasion of the fifth UC San Diego Entrepreneur Challenge, Mr. Ernest Rady, founding Chairman and CEO of Westcorp, presented the Inaugural Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship to Dr. Philip Low, Founder, Chairman and CEO of California Neurotechnology Company, NeuroVigil.
In his acceptance speech, Dr. Low encouraged scientists to learn to become entrepreneurs instead of necessarily relying on outside experts to run their companies. This is especially important in companies where key technology and business decisions are interdependent. Dr. Low also critiqued what has been widely dubbed as the "San Diego Model" wherein entrepreneurs would only limit themselves to creating technology licensing boutiques for larger companies. "Surely the city of Ellen Scripps, of Francis Crick, of Jonas Salk, of Irwin Jacobs and Ernest Rady, the city that is the home of the Marines and the SEALS and the city that calls its airport Lindbergh Field, can do better than that." Low said, rousing applause from a crowd of young entrepreneurs. "There are many more Qualcomms, Googles and Genentechs to build. Let's go to work!" said Dr. Low.
|
|
|
| |
NeuroVigil in the News
Singularity Hub, 26 May 2011
"Understanding brain activity during sleep, researchers think, may unlock the secrets to understanding a range of neurological disorders including Alzheimer's, schizophrenia and depression. The new device is such a significant improvement over existing technologies that it has attracted private funding that raises the company valuation to $250 million..."
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Dr. Philip Low on Annual list of 35 Innovators Under 35
Technology Review, 25 Aug 2010
Portable devices for monitoring brain activity
"The device is small enough to be worn on a headband, so subjects can sleep at home rather than at a clinic. To make life even easier for subjects, the company is developing a version of the device that gathers data and beams it to a subject's cell phone, which can then send it wirelessly to NeuroVigil for analysis."
|
|
|
| |
San Diego phenom named top innovator
San Diego Union-Tribune, 25 Aug 2010
"We're introducing noninvasive (brain) probes which people can use at home."
"The work has attracted the interest of giant pharmaceutical companies. In October, NeuroVigil signed a deal with Swiss drugmaker Roche to supply iBrain devices for clinical drug trials. The device will be used to detect subtle changes in brain activity at low doses before visible signs of side effects surface..."
|
|
|
| |
|
|
| |
|
|
| |
Revolutionizing Sleep Science
Huffington Post, 26 Jan 2010
"The size of two pennies, the miniature iBrain marks what scientists, doctors and venture capitalists see as holding the potential to revolutionize the study of sleep, speed the diagnosis of disease and tap into the multibillion dollar sleep and neurodiagnostics markets. 'We are about to give people access to their own brain,' Low says with cool confidence." |
|
|
| |
|
|
| |
|
|
| |
"Roche inks deal with sleep monitoring start-up"
MobiHealth News, 2 Nov 2009
"...Wireless sensor and neuropathology start-up NeuroVigil has inked a deal with Swiss pharamceutical company Roche. NeuroVigil will provide Roche with its iBrain wireless sensors to help the company collect and analyze data during its clinical trials. NeuroVigil technology will be used to help the company's development of various drugs for CNS disorders..."
|
| |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
In Sleep, We Are Birds of a Feather
The New York Times, 1 Jul 2008
Philip Steven Low of the Salk Institute for Biological Studies in San Diego, Calif., and colleagues report in The Proceedings of the National Academy of Sciences that electroencephalograms of the songbirds show they have episodes of rapid-eye-movement sleep and slow-wave sleep as well as transition stages and quick spikes, all reminiscent of mammalian sleep patterns. |
|
|
| |
|
|
| |
More news...
|
